Insider Transactions in Q3 2023 at Better Therapeutics, Inc. (BTTX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 27
2023
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
1,233,045
+8.64%
|
$0
$0.73 P/Share
|
|
Jul 27
2023
|
Geoffrey M. Parker |
BUY
Open market or private purchase
|
Direct |
685,025
+39.99%
|
$0
$0.73 P/Share
|
|
Jul 27
2023
|
Frank Karbe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
137,005
+24.19%
|
$0
$0.73 P/Share
|
|
Jul 27
2023
|
Elder Granger |
BUY
Open market or private purchase
|
Direct |
34,251
+48.86%
|
$0
$0.73 P/Share
|
|
Jul 27
2023
|
Andrew J. Armanino |
BUY
Open market or private purchase
|
Indirect |
274,010
+27.34%
|
$0
$0.73 P/Share
|
|
Jul 27
2023
|
Mark A. Berman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
54,802
+12.37%
|
$0
$0.73 P/Share
|